Recurrence of Clostridioides difficile infection: A multicenter study on incidence and risk factors
Maria Adriana Cataldo(University of Antwerp), Nicola Petrosillo(European Society of Clinical Microbiology and Infectious Diseases), Sara Fossati(Azienda Sanitaria Universitaria Integrata di Trieste), Enrica Giacometti(University of Udine), Guido Granata(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Erica Franceschini(University of Modena and Reggio Emilia), Filippo Lagi(Policlinico Umberto I), Emanuela Caraffa(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Daniele Roberto Giacobbe(Ospedale Policlinico San Martino), Alessandro Pandolfo(Alessandro Manzoni Hospital), Raffaella Borromeo(Azienda Ospedaliera Ospedale Maggiore), Lucia Adamoli(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Filippo Trapani(Azienda USL di Bologna), A. Oliva(Policlinico Umberto I), A. Lombardi(Policlinico San Matteo Fondazione)
Cited by 0
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424